Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence

Chin Med J (Engl). 2021 Feb 15;134(13):1513. doi: 10.1097/CM9.0000000000001340.

Authors

Yong-Hua Gao¹, Rong-Chang Chen²

Affiliations

¹ Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
² Pulmonary and Critical Care Department, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, Guangdong 518020, China.

No abstract available

Publication types

Editorial

MeSH terms

Administration, Inhalation
Adrenal Cortex Hormones / therapeutic use
Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents / therapeutic use
Drug Therapy, Combination
Humans
Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents